Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
About this item
Full title
Author / Creator
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Subjects
More information
Scope and Contents
Contents
Perampanel is an approved anti-seizure drug. A new formulation of perampanel fine granules (FG; 1% perampanel) has been developed for patients who are unable to take tablets. Bioequivalence between the 4-mg FG and tablet perampanel formulations, as well as their safety and tolerability, were assessed.
In this phase I, single-center, open-label,...
Alternative Titles
Full title
Bioequivalence of perampanel fine granules and tablets in healthy Japanese subjects
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7659282
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7659282
Other Identifiers
ISSN
0946-1965
DOI
10.5414/CP203781
